Cited by 445Cancer-related molecular mechanisms researchCancer-related Molecular PathwaysRNA Research and Splicing

LincRNA-p21 Activates p21 In cis to Promote Polycomb Target Gene Expression and to Enforce the G1/S Checkpoint

Open access
Dimitrova, Nadya, Zamudio, Jesse R., Jong, Robyn M., Soukup, Dylan, Resnick, Rebecca, Sarma, Kavitha, Ward, Amanda J., Raj, Arjun +3 more·2014·Molecular Cell

Abstract

The p53-regulated long noncoding RNA lincRNA-p21 has been proposed to act in trans via several mechanisms ranging from repressing genes in the p53 transcriptional network to regulating mRNA translation and protein stability. To further examine lincRNA-p21 function, we generated a conditional knockout mouse model. We find that lincRNA-p21 predominantly functions in cis to activate expression of its neighboring gene, p21. Mechanistically, we show that lincRNA-p21 acts in concert with hnRNP-K as a coactivator for p53-dependent p21 transcription. Additional phenotypes of lincRNA-p21 deficiency could be attributed to diminished p21 levels, including deregulated expression and altered chromatin state of some Polycomb target genes, a defective G1/S checkpoint, increased proliferation rates, and enhanced reprogramming efficiency. These findings indicate that lincRNA-p21 affects global gene expression and influences the p53 tumor suppressor pathway by acting in cis as a locus-restricted coactivator for p53-mediated p21 expression.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.molcel.2014.04.025

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In the case of lincRNA-p21, the low stability and low copy numbers found make it unlikely that lincRNA-p21 directly regulates many target genes.

    “In the case of lincRNA-p21, the low stability and low copy numbers found make it unlikely that lincRNA-p21 directly regulates many target genes.129”

    From Census and evaluation of p53 target genes (2017) · cites this paper as [129]

  • lincRNA-p21 supports p21 upregulation in response to p53 activation.

    “One such mechanism was suggested for lincRNA-p21, which supports p21 upregulation in response to p53 activation.129”

    From Census and evaluation of p53 target genes (2017) · cites this paper as [129]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

1 retracted

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Dimitrova, N., Zamudio, J. R., Jong, R. M., Soukup, D., Resnick, R., Sarma, K., Ward, A. J., Raj, A., Lee, J. T., Sharp, P. A., & Jacks, T.
Affiliations
  • Koch Institute for Integrative Cancer Research At MIT (US)
  • Massachusetts General Hospital (US)
  • Ionis Pharmaceuticals (United States) (US)
  • University of Pennsylvania (US)
  • Howard Hughes Medical Institute (US)
Corresponding author
Jacks, Tyler
Venue
Molecular Cell
Publisher
Elsevier BV
Published
2014-06
Volume
54
Issue
5
Pages
777-790
ISSN
1097-2765 (ISSN-L)
OpenAlex
W2017844161
Cited by
445
References
39
Citations by year
2026: 12 · 2025: 13 · 2024: 19 · 2023: 30 · 2022: 33 · 2021: 47 · 2020: 46 · 2019: 37 · 2018: 49 · 2017: 61 · 2016: 48 · 2015: 39 · 2014: 10
FWCI
16.87
Type
journal article
Language
en
Open access
Locations
  • Molecular Cell (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion, cc-by-nc-nd)
  • PMC
Funders
  • Howard Hughes Medical Institute
  • Damon Runyon Cancer Research Foundation
  • National Institutes of Health (1dp2od008514-01)
  • Ludwig Center for Molecular Oncology
  • Ludwig Center at Harvard
  • National Cancer Institute (R01CA133404, P01CA042063, P30CA014051)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer-related molecular mechanisms research
  • Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Research and Splicing
Keywords
lincRNA-p21, long non-coding RNA, p21, p53, cis-acting regulation, hnRNP K, transcriptional coactivator, p53-dependent transcription, Polycomb target genes, G1/S checkpoint, cell proliferation, cellular reprogramming, conditional knockout mice, chromatin state
MeSH terms
Animals, Cells, Cultured, Transcriptional Activation, Mice, Knockout, Epigenesis, Genetic, Cell Proliferation, Cyclin-Dependent Kinase Inhibitor p21, Mice, Transcriptome, G1 Phase Cell Cycle Checkpoints, RNA, Long Noncoding, Polycomb-Group Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review